Publication | Closed Access
A new imaging agent for medullary carcinoma of the thyroid.
141
Citations
0
References
1984
Year
Neuro-oncologyResidual TumorSerum Calcitonin ValuesMedicineImaging AgentThyroid DiseasePathologyParathyroid GlandThyroid ScintigraphyRadiologic ImagingThyroid HormoneNew Imaging AgentRadiation OncologyNuclear MedicineRadiologyHealth Sciences
Thyroid scintigraphy, using 99mTc(V) dimercaptosuccinic acid, was performed in four patients with pathologically confirmed medullary thyroid carcinoma and elevated serum calcitonin values. Significant uptake of the tracer was found in the clinically palpable cervical tumor masses, metastatic sites, and residual tumor. This finding, probably specific for medullary thyroid carcinoma, could be of great use in the diagnosis and the surgical follow-up.